Home / Import refusals / 799-8003003-7/10003/1

FDA Import Refusal 799-8003003-7/10003/1 — SANDOZ CANADA INCORPORATED

SANDOZ CANADA INCORPORATED — FEI 3040451368

The FDA refused shipment 799-8003003-7/10003/1 from SANDOZ CANADA INCORPORATED (Canada) on December 19, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 19, 2025
Country
Canada
Product Category
Drugs and Biologics
Product Code
61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75

Other import refusals

  • AEK-0526222-4/10002/1 (Thu Jul 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0070056-6/10003/1 (Wed May 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0031789-0/10003/1 (Fri Mar 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0355453-6/10003/1 (Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8952873-4/10003/1 (Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources